Cargando…
Observed risk of recurrent bleeding and thromboembolic disease in COVID-19 patients with gastrointestinal bleeding
Background and study aim COVID-19 patients are at increased risk for venous thromboembolism (VTE) requiring the use of anticoagulation. Gastrointestinal bleeding (GIB) is increasingly being reported, complicating the decision to initiate or resume anticoagulation as providers balance the risk of th...
Autores principales: | Attah, Emmanuel, Martin, Tracey A., Smith, Emily S., Tewani, Sunena, Hajifathalian, Kaveh, Sharaiha, Reem Z., Crawford, Carl V., Wan, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382501/ https://www.ncbi.nlm.nih.gov/pubmed/34466370 http://dx.doi.org/10.1055/a-1497-1801 |
Ejemplares similares
-
Fr012 THE OBSERVED RISK OF RECURRENT BLEEDING AND THROMBOEMBOLIC DISEASE IN COVID-19 PATIENTS WITH GASTROINTESTINAL BLEEDING.
por: Attah, Emmanuel O., et al.
Publicado: (2021) -
Factors Associated With Emergency Department Discharge, Outcomes and Follow-Up Rates of Stable Patients With Lower Gastrointestinal Bleeding
por: Martin, Tracey A., et al.
Publicado: (2021) -
Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications
por: Hajifathalian, Kaveh, et al.
Publicado: (2020) -
Azithromycin versus erythromycin infusions prior to endoscopy in upper gastrointestinal bleeding
por: Issa, Danny, et al.
Publicado: (2022) -
An Overt, Obscure Gastrointestinal Bleed Caused by a Primary Small Bowel Fibroblastic Reticular Cell Sarcoma
por: Gold, Stephanie L., et al.
Publicado: (2018)